Longboard Surfs PACIFIC Waves To Pivotal Phase III Epilepsy Program

 
• By Alaric DeArment
  
Longboard announced results of its Phase Ib/IIa PACIFIC study of bexicaserin in epilepsy, quadrupling its stock price • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D